190 compounds · fully cited · educational only
Understand the compounds.
Trust the evidence.
An independent, citation-backed database of peptide and longevity compounds. Every profile shows research strength, mechanism, legal status by country, and links straight to the underlying studies.
- 190
- Compounds
- 12
- Categories
- 18
- Comparisons
- 0
- Vendor ties
Evidence-rated
Every compound carries a research strength and evidence level, so you know exactly where the science stands.
Cited to the source
Claims link to the actual trials and reviews on PubMed — never to a vendor, a forum, or a guess.
Legal status shown
Classification for the US, UK, Australia, and Canada, printed on every single profile.
No vendor influence
Zero affiliate links, zero sponsored compounds, zero paid placements. Nothing here is for sale.
Index / most researched
Where the science is deepest
Semaglutide
Semaglutide (GLP-1 receptor agonist)
A long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, with proven cardiovascular risk reduction.
Tirzepatide
Tirzepatide (dual GIP/GLP-1 receptor agonist)
A first-in-class dual GIP and GLP-1 receptor agonist with superior weight loss and glycemic control versus GLP-1 mono-agonists.
Retatrutide
Retatrutide (triple GLP-1/GIP/glucagon agonist)
An investigational once-weekly triple receptor agonist producing the largest pharmacological weight loss reported to date in trials.
BPC-157
Body Protection Compound 157
A pentadecapeptide studied extensively in animal models for tendon, ligament, muscle, and gut healing. Human evidence remains limited.
TB-500
Thymosin Beta-4 Synthetic Fragment
A synthetic version of Thymosin Beta-4 studied in animal models for wound healing, tissue repair, and reduced inflammation.
Ipamorelin
Ipamorelin Acetate
A selective growth hormone secretagogue and ghrelin receptor agonist that stimulates pulsatile GH release with minimal effect on cortisol or prolactin.
Guide · 9 min read
The 2026 Obesity Drug Pipeline
Every next-generation weight-loss compound — the triple agonists, the amylin drugs, the oral pills — its mechanism and where it stands, each linked to the cited evidence.
Read the guideHead to head
Popular comparisons
The research digest
Updates when the evidence changes.
Get notified when profiles are reviewed and new studies land. No vendor promotions, ever.
The full library